Skin cancer drug sonidegib under safety watch in Real-World study
NCT ID NCT04066504
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at the long-term safety of the drug sonidegib in 323 adults with a type of skin cancer called locally advanced basal cell carcinoma. Participants took a daily 200 mg pill, and researchers tracked side effects, serious events, and deaths. The goal was to gather real-world safety data, not to test if the drug works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- sonidegib (a drug taken as a daily pill)
- What this could lead to
- If successful, this study will provide important safety information to help doctors better manage patients on sonidegib.
- What could go wrong
- This is an observational study, not a treatment trial, so it does not test if sonidegib works. It only monitors side effects in a real-world setting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AOU Maggiore della Carità - Università del Piemonte Orientale
Novara, Italy
-
ASL1 Avezzano-Sulmona-L'Aquila
L’Aquila, Italy
-
ASST Spedali Civili di Brescia
Brescia, Italy
-
Azienda Toscana Centro - Università di Firenze
Florence, Italy
-
Complejo Hospitalario Universitario de Pontevedra
Pontevedra, 36001, Spain
-
Elbe Kliniken Stade - Buxtehude GmbH
Buxtehude, Germany
-
Fachklinik Muenster-Hornheide
Münster, 48157, Germany
-
Forndazione I.R.C.C.S. Istituto nazionale dei tumori
Milan, 20133, Italy
-
Harzklinikum Dorothea Christiane Erxleben GmbH
Quedlinburg, 06484, Germany
-
Helios Klinikum
Erfurt, 99089, Germany
-
Helios St. Elisabeth Klinik
Oberhausen, 46045, Germany
-
Hospital Clínic de Barcelona
Barcelona, 8036, Spain
-
Hospital General Universitari València
Valencia, 46014, Spain
-
Hospital Germans Trias i Pujol
Badalona, 8916, Spain
-
Hospital Universitario La Fe
Valencia, 46026, Spain
-
Hospital Universitario La Paz
Madrid, 28046, Spain
-
Hospital Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife, 38010, Spain
-
Hospital Universitario Ramón y Cajal
Madrid, 28034, Spain
-
Hospital Universitario de Gran Canaria Doctor Negrín
Las Palmas de Gran Canaria, 35010, Spain
-
Hospital Vall d'Hebron
Barcelona, 8035, Spain
-
Hospital de la Santa Creu i Sant Pau
Barcelona, 8041, Spain
-
I.R.C.C.S Istituto Tumori "Giovanni Paolo II"
Bari, Italy
-
IDI
Roma, 00167, Italy
-
Inselspital
Bern, Switzerland
-
Ist. Scien. Romagnolo per lo Studio e la Cura dei Tumori - IRST
Meldola, 47014, Italy
-
Istituto Tumori Napoli Fondazione G. Pascale
Naples, 80131, Italy
-
Johannes Wesling Klinikum Minden
Minden, 32429, Germany
-
Katholisches Klinikum Bochum St. Josef-Hospital
Bochum, Germany
-
Klinikum Darmstadt GmbH
Darmstadt, 64297, Germany
-
Klinikum Ludwigshafen gGmbH
Ludwigshafen, Germany
-
Klinikum rechts der Isar
München, 80802, Germany
-
Medizinische Hochschule Hannover
Hanover, '30625, Germany
-
Ospedale Policlinico San Martino
Genova, 16132, Italy
-
SRH Wald-Klinikum
Gera, 07548, Germany
-
Universitaets-Hautklinik Kiel
Kiel, Germany
-
Universitaetsklinikum Essen
Essen, Germany
-
Universitaetsklinikum Schleswig-Holstein
Lübeck, Germany
-
Universitaetsklinikum Tuebingen
Tübingen, Germany
-
Università Cattolica del Sacro Cuore
Roma, 00168, Italy
-
Università Degli Studi di Napoli Federico II
Naples, Italy
-
Universitätsklinik Carl Gustav Carus der Technischen Universität Dresden
Dresden, 1307, Germany
-
Universitätsklinik Magdeburg
Magdeburg, 39120, Germany
-
Universitätsklinikum Freiburg
Freiburg im Breisgau, 79104, Germany
-
Universitätsklinikum Hamburg-Eppendorf
Hamburg, 20246, Germany
-
Universitätsklinikum Regensburg
Regensburg, 93053, Germany
-
Universitätsklinikum Ulm
Ulm, 89081, Germany
-
Universitätsspital Zürich
Zurich, CH- 8091, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Botox before the knife: could a Pre-Surgery injection lead to Better-Looking scars?
- Could a lighter immunotherapy schedule keep advanced cancers in check?
- New skin patch could speed recovery after skin cancer removal
- AI reads skin lesions to predict cancer aggressiveness
- Needle-Free light therapy shows promise for common skin cancer
- Snap and measure: new photo method tracks nose shape after skin cancer surgery